Petros Pharmaceuticals Inc. (NASDAQ: PTPI) stock jumped 3.03% on Friday to $0.82 against a previous-day closing price of $0.80. With 37.12 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.24 million shares. During the session, the Drug Manufacturers – Specialty & Generic company that operates in wider Healthcare sector, reached to the highest price of $2.8800 whereas the lowest price it dropped to was $0.6701. The 52-week range on PTPI shows that it touched its highest point at $5.20 and its lowest point at $0.65 during that stretch.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
Sponsored
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of PTPI was down-trending over the past week, with a drop of -13.96%, but this was down by -9.25% over a month. Three-month performance dropped to -27.43% while six-month performance fell -51.76%. The stock lost -73.46% in the past year, while it has lost -75.38% so far this year.
Float and Shares Shorts:
At present, 20.68 million PTPI shares are outstanding with a float of 14.47 million shares on hand for trading. On Apr 28, 2022, short shares totaled 0.14 million, which was 0.66% higher than short shares on Mar 30, 2022. In addition to Mr. John D. Shulman as the firm’s Exec. Chairman, Mr. Fady Boctor M.B.A. serves as its Principal Exec. Officer, Pres & Chief Commercial Officer.
Institutional Ownership:
Through their ownership of 6.52% of PTPI’s outstanding shares, institutional investors have minority control over the company. Other institutions hold 44.10% of PTPI, in contrast to 3.95% held by mutual funds. Shares owned by individuals account for 0.92%. As the largest shareholder in PTPI with 0.92% of the stake, BlackRock Fund Advisors holds 190,416 shares worth 190,416. A second-largest stockholder of PTPI, Iroquois Capital Management LLC, holds 167,820 shares, controlling over 0.81% of the firm’s shares. Marshall Wace LLP is the third largest shareholder in PTPI, holding 131,196 shares or 0.63% stake. With a 0.58% stake in PTPI, the Vanguard Extended Market Index Fu is the largest stakeholder. A total of 119,141 shares are owned by the mutual fund manager. The Fidelity Extended Market Index Fu, which owns about 0.24% of PTPI stock, is the second-largest Mutual Fund holder. It holds 50,225 shares valued at 42189.0. Fidelity Series Total Market Inde holds 0.06% of the stake in PTPI, owning 11,591 shares worth 9736.0.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for PTPI since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With PTPI analysts setting a high price target of – and a low target of –, the average target price over the next 12 months is –.
Summary of Insider Activity:
Insiders traded PTPI stock several times over the past three months with 0 Buys and 0 Sells. In these transactions, 0 shares were bought while 0 shares were sold. The number of buy transactions has increased to 3 while that of sell transactions has remained unmoved to 0 over the past year. The total number of shares bought during that period was 2,307,580 while 0 shares were sold.
